Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caffeine and Dipyridamole Interaction in Ischemia-Reperfusion
NCT00430170Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2007
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dipyridamole in ischemia-reperfusion injury (IRI), sponsored by Radboud University Medical Center. Started Jan 2007; status: completed.
02
Drugs
dipyridamole
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT00430170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00430170.